Definium Therapeutics, Inc. (DFTX)
20.78
+0.18
(+0.87%)
USD |
NASDAQ |
Apr 02, 11:08
Definium Therapeutics Research and Development Expense (TTM) : 117.66M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pulse Biosciences, Inc. | 44.72M |
| RxSight, Inc. | 38.55M |
| Plus Therapeutics, Inc. | 8.379M |
| Viridian Therapeutics, Inc. | 338.47M |
| Nutriband, Inc. | 2.193M |